April 18, 2017

Mobidiag to boost its presence around the globe

Mobidiag is about to strengthen its marketing and sales in Europe and elsewhere.
Mobidiag is about to strengthen its marketing and sales in Europe and elsewhere.
Istock.com / Cecilie_Arcurs

Molecular diagnostics company Mobidiag is heavily investing in its global sales and marketing channels, now with the help of recent funding.

Mobidiag has secured funding worth almost four million euros, supported by the Finnish investment service company Kansalaisrahoitus. The funding was completed before the closing date by over 300 investors, and it adds to a 15-million-euro loan from the European Investment Bank.

The money enables Mobidiag to finalise and scale up its manufacturing and assay validation, as well as to fuel its sales and marketing efforts.

“We were very happy with the share issue organised by Kansalaisrahoitus, which was achieved very professionally and fast,” says Tuomas Tenkanen, CEO of Mobidiag. “This type of financing completes perfectly traditional ones.”

Mobidiag provides solutions in vitro diagnostics of infectious diseases. Just recently, the company announced a collaboration with Italian AB ANALITICA, as well as opened an office in the UK.

Share: